Organization
Chengdu Kanghong Biotech
1 clinical trial
Clinical trial
A Phase 3 Clinical Trial of Intravitreal Injections of Human Recombinant Vascular Endothelial Growth Factor Receptor-Fc Fusion Protein in Patients With Choroidal Neovascularization Secondary to Age-related Macular DegenerationStatus: Completed, Estimated PCD: 2012-12-01